Skip to main content
. 2020 Jul 2;27(1):996–1009. doi: 10.1080/10717544.2020.1787557

Figure 8.

Figure 8.

Mean sofosbuvir concentrations (ng/mL) in the liver after oral administration of the optimized bilosomal formula as a lyophilized powder (LOBF) before and after galactosylation, in comparison with the drug solution.